{"organizations": [], "uuid": "c32b5898dd1b8e8f53b0b33e850db11a489b8965", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-opiant-pharmaceuticals-to-record-a/brief-opiant-pharmaceuticals-to-record-about-11-7-million-in-royalty-idUSASB0C4S3", "country": "US", "domain_rank": 408, "title": "BRIEF-Opiant Pharmaceuticals To Record About $11.7 Million In Royalty", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.582, "site_type": "news", "published": "2018-02-08T21:12:00.000+02:00", "replies_count": 0, "uuid": "c32b5898dd1b8e8f53b0b33e850db11a489b8965"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-opiant-pharmaceuticals-to-record-a/brief-opiant-pharmaceuticals-to-record-about-11-7-million-in-royalty-idUSASB0C4S3", "ord_in_thread": 0, "title": "BRIEF-Opiant Pharmaceuticals To Record About $11.7 Million In Royalty", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "opiant pharmaceuticals inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - Opiant Pharmaceuticals Inc:\n* OPIANT PHARMACEUTICALS TO RECORD APPROXIMATELY $11.7 MILLION IN ROYALTY AND MILESTONE PAYMENTS RELATED TO 2017 SALES OF NARCAN® NASAL SPRAY FOR OPIOID OVERDOSE\n* OPIANT PHARMACEUTICALS - ‍WILL RECORD TOTAL OF ABOUT $11.7 MILLION ROYALTY, MILESTONE PAYMENTS FOR 5-MONTH TRANSITION PERIOD ENDED DECEMBER 31, 2017​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T21:12:00.000+02:00", "crawled": "2018-02-09T16:42:01.008+02:00", "highlightTitle": ""}